Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01732406 · ClinicalTrials.gov registry record
Acromegaly Treatment Quality of Life Study
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 126
- Enrollment target
NCT01732406: Completed study, sponsored by Massachusetts General Hospital.
NCT01732406 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 126 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01732406 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 126 participants
- Enrollment target
Study Summary
The investigators hypothesize that treatment of acromegaly will be associated with an improvement in quality of life compared to active acromegaly. At the same time, they will also be studying the effects of different acromegaly treatments on the quality of life.
Primary Outcome
The Global Score of the Acromegaly Quality of Life (ACROQoL) Survey measures quality of life in patients with acromegaly. Higher scores indicate better QOL. The range is 22-110 units on a scale.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2013-01 |
| Est. Completion | 2016-12-19 |
What the finished NCT01732406 record still lists
NCT01732406 is an observational study that tracks outcomes without assigning an intervention. The registered 126 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01732406 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01732406 about?
NCT01732406 is a clinical study titled "Acromegaly Treatment Quality of Life Study". The investigators hypothesize that treatment of acromegaly will be associated with an improvement in quality of life compared to active acromegaly. At the same time, they will also be studying the effects of different acromegaly treatments on the quality of life.
What is the current status of trial NCT01732406?
This trial is currently completed. The enrollment target is 126 participants. The study started on 2013-01. Estimated completion is 2016-12-19.
Who is sponsoring clinical trial NCT01732406?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01873131 · 126 participants · NA
A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn
- NCT02621645 · 126 participants · Phase 4
TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence
- NCT03838107 · 126 participants
Markers of Trajectory in Pediatric CRPS
- NCT03906422 · 126 participants · NA
Comparison of Patient-reported Pain After Initial Archwire Placement
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia